The mechanical thrombectomy devices market size has grown strongly in recent years. It will grow from $1.52 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to limited availability of mechanical thrombectomy devices, reliance on manual procedures for stroke treatment, growing awareness of stroke and cardiovascular risks, increasing hospital infrastructure for interventional procedures, adoption of catheter-based interventions.
The mechanical thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to development of automated and electromechanical thrombectomy devices, rising prevalence of ischemic stroke and coronary thrombosis, integration of ai-assisted device navigation, expansion of ambulatory surgical centers and specialized invasive care centers, increasing r&d investments in thrombectomy technologies. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of combined thrombectomy devices, growth in electromechanical and hybrid device segment, expansion of ischemic stroke treatment procedures, enhanced focus on device safety and regulatory compliance.
The rising prevalence of stroke is expected to drive growth in the mechanical thrombectomy devices market in the coming years. Stroke occurs when blood flow to a part of the brain is interrupted or reduced, leading to brain cell death from a lack of oxygen and nutrients. The increasing incidence of stroke is largely due to aging populations, as older individuals face higher risks because of natural changes in blood vessels and overall health. Mechanical thrombectomy devices play a critical role in stroke treatment by rapidly removing blood clots from blocked brain arteries, restoring blood flow, minimizing brain damage, and significantly improving patient recovery outcomes. For example, in October 2023, the World Economic Forum, a Switzerland-based non-profit organization, reported that stroke deaths could rise by 50% by 2050. This trend underscores how the growing prevalence of stroke is fueling demand for mechanical thrombectomy devices.
Companies in the mechanical thrombectomy devices market are advancing technology to improve the efficiency and safety of procedures. Innovations such as dual clot detection algorithms are being developed to enhance clot removal while ensuring patient safety. These algorithms use both pressure and flow data to accurately identify and distinguish blood clots from normal blood flow during thrombectomy. For instance, in January 2023, Penumbra Inc., a US-based healthcare company, launched the Lightning Flash system, an advanced mechanical thrombectomy device designed to revolutionize clot removal. Combining powerful aspiration technology with a precision-engineered catheter, it efficiently and safely removes large blood clots, including venous thrombi and pulmonary emboli, enabling faster procedures while minimizing complications and improving patient outcomes.
In February 2025, Stryker Corporation, a US-based medical technology company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aims to substantially expand its interventional endovascular portfolio, particularly within the high-growth venous thromboembolism (VTE) and thrombectomy segments. Inari Medical Inc. is a US-based medical device company specializing in mechanical thrombectomy solutions, including the FlowTriever system for pulmonary embolism and the ClotTriever system for peripheral vessel clot removal.
Major companies operating in the mechanical thrombectomy devices market are Stryker Corporation, Medtronic plc, Penumbra Inc., Terumo Corporation, Boston Scientific Corporation, Johnson & Johnson, Edwards Lifesciences Corporation, AngioDynamics Inc., Acandis GmbH & Co. KG, Rapid Medical, Vesalio, Control Medical Technology LLC, Perflow Medical, Sino Medical Sciences Technology Inc., Natec Medical Ltd., Straub Medical AG, Vascular Medcure Inc., Imperative Care Inc., NeuroVasc Technologies Inc., Inquis Medical Inc., Balt Extrusion S.A.S., Anaconda Biomed SL, SILK Road Medical Inc., Argon Medical Devices Inc., Minnetronix Inc.
North America was the largest region in the mechanical thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical thrombectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mechanical thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mechanical thrombectomy devices market by increasing the cost of imported stent retrievers, aspiration catheters, and electromechanical devices. Segments such as hybrid devices and powered aspiration devices are most impacted, particularly in Asia-Pacific regions like China and India that serve as key manufacturing hubs. These tariffs have led to higher production costs and supply chain disruptions. On the positive side, tariffs are encouraging domestic manufacturing, innovation in device design, and investment in local production capabilities.
The mechanical thrombectomy devices market research report is one of a series of new reports that provides mechanical thrombectomy devices market statistics, including mechanical thrombectomy devices industry global market size, regional shares, competitors with a mechanical thrombectomy devices market share, detailed mechanical thrombectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the mechanical thrombectomy devices industry. This mechanical thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mechanical thrombectomy devices are medical instruments designed to physically remove blockages from blood vessels using minimally invasive techniques. They are engineered to navigate precisely through the vascular system, allowing for the safe capture and extraction of obstructions while minimizing damage to surrounding tissues. These devices feature controlled operation, effective grasping mechanisms, and reliable retrieval capabilities, helping to restore normal blood flow within the affected vessel.
The primary types of mechanical thrombectomy devices include stent retrievers, catheter-based thrombectomy devices, mechanical aspiration devices, and combination devices. Stent retrievers are specifically used to remove blood clots from blocked cerebral arteries during stroke treatment by temporarily trapping and extracting the clot. These devices utilize various technologies, including manual mechanical thrombectomy devices, automated devices, electromechanical systems, and hybrid models. They are applied in treating ischemic stroke, peripheral artery disease (PAD), coronary thrombosis, and post-surgical thrombosis, and are distributed through direct sales, distributors and wholesalers, online platforms, and retail pharmacies. Key end users include hospitals, ambulatory surgical centers, specialized invasive care centers, and research and academic institutions.
The mechanical thrombectomy devices market consists of sales of guidewires, microcatheters, balloon catheters, aspiration pumps, embolic protection devices, angioplasty balloons, contrast media, and hemostatic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The mechanical thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to development of automated and electromechanical thrombectomy devices, rising prevalence of ischemic stroke and coronary thrombosis, integration of ai-assisted device navigation, expansion of ambulatory surgical centers and specialized invasive care centers, increasing r&d investments in thrombectomy technologies. Major trends in the forecast period include rising adoption of minimally invasive procedures, increasing use of combined thrombectomy devices, growth in electromechanical and hybrid device segment, expansion of ischemic stroke treatment procedures, enhanced focus on device safety and regulatory compliance.
The rising prevalence of stroke is expected to drive growth in the mechanical thrombectomy devices market in the coming years. Stroke occurs when blood flow to a part of the brain is interrupted or reduced, leading to brain cell death from a lack of oxygen and nutrients. The increasing incidence of stroke is largely due to aging populations, as older individuals face higher risks because of natural changes in blood vessels and overall health. Mechanical thrombectomy devices play a critical role in stroke treatment by rapidly removing blood clots from blocked brain arteries, restoring blood flow, minimizing brain damage, and significantly improving patient recovery outcomes. For example, in October 2023, the World Economic Forum, a Switzerland-based non-profit organization, reported that stroke deaths could rise by 50% by 2050. This trend underscores how the growing prevalence of stroke is fueling demand for mechanical thrombectomy devices.
Companies in the mechanical thrombectomy devices market are advancing technology to improve the efficiency and safety of procedures. Innovations such as dual clot detection algorithms are being developed to enhance clot removal while ensuring patient safety. These algorithms use both pressure and flow data to accurately identify and distinguish blood clots from normal blood flow during thrombectomy. For instance, in January 2023, Penumbra Inc., a US-based healthcare company, launched the Lightning Flash system, an advanced mechanical thrombectomy device designed to revolutionize clot removal. Combining powerful aspiration technology with a precision-engineered catheter, it efficiently and safely removes large blood clots, including venous thrombi and pulmonary emboli, enabling faster procedures while minimizing complications and improving patient outcomes.
In February 2025, Stryker Corporation, a US-based medical technology company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aims to substantially expand its interventional endovascular portfolio, particularly within the high-growth venous thromboembolism (VTE) and thrombectomy segments. Inari Medical Inc. is a US-based medical device company specializing in mechanical thrombectomy solutions, including the FlowTriever system for pulmonary embolism and the ClotTriever system for peripheral vessel clot removal.
Major companies operating in the mechanical thrombectomy devices market are Stryker Corporation, Medtronic plc, Penumbra Inc., Terumo Corporation, Boston Scientific Corporation, Johnson & Johnson, Edwards Lifesciences Corporation, AngioDynamics Inc., Acandis GmbH & Co. KG, Rapid Medical, Vesalio, Control Medical Technology LLC, Perflow Medical, Sino Medical Sciences Technology Inc., Natec Medical Ltd., Straub Medical AG, Vascular Medcure Inc., Imperative Care Inc., NeuroVasc Technologies Inc., Inquis Medical Inc., Balt Extrusion S.A.S., Anaconda Biomed SL, SILK Road Medical Inc., Argon Medical Devices Inc., Minnetronix Inc.
North America was the largest region in the mechanical thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical thrombectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mechanical thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the mechanical thrombectomy devices market by increasing the cost of imported stent retrievers, aspiration catheters, and electromechanical devices. Segments such as hybrid devices and powered aspiration devices are most impacted, particularly in Asia-Pacific regions like China and India that serve as key manufacturing hubs. These tariffs have led to higher production costs and supply chain disruptions. On the positive side, tariffs are encouraging domestic manufacturing, innovation in device design, and investment in local production capabilities.
The mechanical thrombectomy devices market research report is one of a series of new reports that provides mechanical thrombectomy devices market statistics, including mechanical thrombectomy devices industry global market size, regional shares, competitors with a mechanical thrombectomy devices market share, detailed mechanical thrombectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the mechanical thrombectomy devices industry. This mechanical thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Mechanical thrombectomy devices are medical instruments designed to physically remove blockages from blood vessels using minimally invasive techniques. They are engineered to navigate precisely through the vascular system, allowing for the safe capture and extraction of obstructions while minimizing damage to surrounding tissues. These devices feature controlled operation, effective grasping mechanisms, and reliable retrieval capabilities, helping to restore normal blood flow within the affected vessel.
The primary types of mechanical thrombectomy devices include stent retrievers, catheter-based thrombectomy devices, mechanical aspiration devices, and combination devices. Stent retrievers are specifically used to remove blood clots from blocked cerebral arteries during stroke treatment by temporarily trapping and extracting the clot. These devices utilize various technologies, including manual mechanical thrombectomy devices, automated devices, electromechanical systems, and hybrid models. They are applied in treating ischemic stroke, peripheral artery disease (PAD), coronary thrombosis, and post-surgical thrombosis, and are distributed through direct sales, distributors and wholesalers, online platforms, and retail pharmacies. Key end users include hospitals, ambulatory surgical centers, specialized invasive care centers, and research and academic institutions.
The mechanical thrombectomy devices market consists of sales of guidewires, microcatheters, balloon catheters, aspiration pumps, embolic protection devices, angioplasty balloons, contrast media, and hemostatic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Mechanical Thrombectomy Devices Market Characteristics
3. Mechanical Thrombectomy Devices Market Supply Chain Analysis
4. Global Mechanical Thrombectomy Devices Market Trends and Strategies
5. Mechanical Thrombectomy Devices Market Analysis of End Use Industries
7. Global Mechanical Thrombectomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Mechanical Thrombectomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Mechanical Thrombectomy Devices Market Segmentation
10. Mechanical Thrombectomy Devices Market Regional and Country Analysis
11. Asia-Pacific Mechanical Thrombectomy Devices Market
12. China Mechanical Thrombectomy Devices Market
13. India Mechanical Thrombectomy Devices Market
14. Japan Mechanical Thrombectomy Devices Market
15. Australia Mechanical Thrombectomy Devices Market
16. Indonesia Mechanical Thrombectomy Devices Market
17. South Korea Mechanical Thrombectomy Devices Market
18. Taiwan Mechanical Thrombectomy Devices Market
19. South East Asia Mechanical Thrombectomy Devices Market
20. Western Europe Mechanical Thrombectomy Devices Market
21. UK Mechanical Thrombectomy Devices Market
22. Germany Mechanical Thrombectomy Devices Market
23. France Mechanical Thrombectomy Devices Market
24. Italy Mechanical Thrombectomy Devices Market
25. Spain Mechanical Thrombectomy Devices Market
26. Eastern Europe Mechanical Thrombectomy Devices Market
27. Russia Mechanical Thrombectomy Devices Market
28. North America Mechanical Thrombectomy Devices Market
29. USA Mechanical Thrombectomy Devices Market
30. Canada Mechanical Thrombectomy Devices Market
31. South America Mechanical Thrombectomy Devices Market
32. Brazil Mechanical Thrombectomy Devices Market
33. Middle East Mechanical Thrombectomy Devices Market
34. Africa Mechanical Thrombectomy Devices Market
36. Mechanical Thrombectomy Devices Market Competitive Landscape and Company Profiles
37. Mechanical Thrombectomy Devices Market Other Major and Innovative Companies
40. Mechanical Thrombectomy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Mechanical Thrombectomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses mechanical thrombectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for mechanical thrombectomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mechanical thrombectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Stent Retrievers; Catheter-Based Thrombectomy Devices; Mechanical Aspiration Devices; Combined Devices2) By Technology: Manual Mechanical Thrombectomy Devices; Automated Mechanical Thrombectomy Devices; Electromechanical Thrombectomy Devices; Hybrid Devices
3) By Application: Ischemic Stroke; Peripheral Artery Disease (PAD); Coronary Thrombosis; Post-Surgical Thrombosis
4) By Distribution Channel: Direct Sales; Distributors And Wholesalers; Online Sales; Retail Pharmacies
5) By End User: Hospitals; Ambulatory Surgical Centers; Specialized Invasive Care Centers; Research And Academic Institutions
Subsegments:
1) By Stent Retrievers: Closed-Cell Stent Retrievers; Open-Cell Stent Retrievers; Hybrid Stent Retrievers2) By Catheter-Based Thrombectomy Devices: Aspiration Catheters; Guide Catheters; Micro Catheters
3) By Mechanical Aspiration Devices: Manual Aspiration Devices; Powered Aspiration Devices
4) By Combined Devices: Aspiration Plus Stent Retrievers; Aspiration Plus Mechanical Devices
Companies Mentioned: Stryker Corporation; Medtronic plc; Penumbra Inc.; Terumo Corporation; Boston Scientific Corporation; Johnson & Johnson; Edwards Lifesciences Corporation; AngioDynamics Inc.; Acandis GmbH & Co. KG; Rapid Medical; Vesalio; Control Medical Technology LLC; Perflow Medical; Sino Medical Sciences Technology Inc.; Natec Medical Ltd.; Straub Medical AG; Vascular Medcure Inc.; Imperative Care Inc.; NeuroVasc Technologies Inc.; Inquis Medical Inc.; Balt Extrusion S.A.S.; Anaconda Biomed SL; SILK Road Medical Inc.; Argon Medical Devices Inc.; Minnetronix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Mechanical Thrombectomy Devices market report include:- Stryker Corporation
- Medtronic plc
- Penumbra Inc.
- Terumo Corporation
- Boston Scientific Corporation
- Johnson & Johnson
- Edwards Lifesciences Corporation
- AngioDynamics Inc.
- Acandis GmbH & Co. KG
- Rapid Medical
- Vesalio
- Control Medical Technology LLC
- Perflow Medical
- Sino Medical Sciences Technology Inc.
- Natec Medical Ltd.
- Straub Medical AG
- Vascular Medcure Inc.
- Imperative Care Inc.
- NeuroVasc Technologies Inc.
- Inquis Medical Inc.
- Balt Extrusion S.A.S.
- Anaconda Biomed SL
- SILK Road Medical Inc.
- Argon Medical Devices Inc.
- Minnetronix Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.67 Billion |
| Forecasted Market Value ( USD | $ 2.36 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
